Q&A: Understanding the Role of Tirzepatide, Semaglutide in Cardiovascular Disease
As clinical research continues, investigators are learning more about how GLP-1 drugs modify cardiovascular risks.
Q&A: Examining the Key Drivers of a Healthful Lifestyle
Lifestyle changes—including eating fruits, vegetables, and whole grains—can help patients, especially those with diabetes or hypertension, improve outcomes.
Video: Top Tips for Patients to Encourage Healthful Diet and Lifestyle
Sharing concrete steps and suggestions can help ease the way for patients looking to transition to a more healthful lifestyle.
Healthful Diets Are Crucial, But Population-Level Follow-Through Remains a Challenge
Health care professionals all agree that a healthy diet is the foundation of cardiovascular and cardiometabolic health, but follow-through on the population level is lacking.
A Deeper Understanding of GLP-1 Mechanism of Action Will Open Doors for Future Uses
GLP-1 therapies are being evaluated to treat cardiovascular and kidney diseases in individuals with overweight or obesity.
Q&A: Understanding Benefits, Managing Adverse Effects of GLP-1 Receptor Agonists
These therapies are highly beneficial, but can come with a host of gastrointestinal adverse effects that patients may not be prepared to manage alone.
Managing “Class Action” Adverse Effects Crucial for GLP-1 Medication Adherence
Some patients may have difficulty managing the gastrointestinal adverse effects associated with GLP-1 therapies.
Benefits of GLP-1s Transcend Simple Weight Loss for Individuals With Overweight, Obesity, and Comorbidities
Losing even 5% of body weight can improve comorbid conditions and other health complications for individuals with overweight and obesity.
